Dengue Virus IgG Capture ELISA Kit

A Sandwich ELISA kit for the qualitative detect Dengue Virus IgG in human serum or plasma.

WARNING: This product can expose you to chemicals including TMB, which is [are] known to the State of California to cause cancer.  For more information go to
Catalog #: E4670 | abID:

Product Details

Cat # +Size E4670-100
Size 96 assays
Detection Method Absorbance (450 nm)
Species Reactivity Human
Applications This ELISA kit is used for quantitative measurement of Dengue Virus IgG in serum and plasma.
Features & Benefits • Easy, convenient and time-saving method to measure the level of Dengue Virus IgG in serum and plasma.
• No significant cross-reactivity or interference was observed.
Kit Components • MicroPlate
• Wash Buffer (20X)
• Sample Diluent
• Calibrator
• Positive Control
• Negative Control
• Anti-human IgG Biotin Conjugate
• Dengue Enzyme conjugate
• TMB Substrate
• Stop Solution
Storage Conditions 4°C
Shipping Conditions Gel Pack
USAGE For Research Use Only! Not For Use in Humans.


The mosquito-borne dengue viruses (serotype 1-4) cause dengue fever, a severe flu-like illness. The disease is prevalent in Third World tropical regions and spreading to sub-tropical developed countries - including the United States. WHO estimates that 50-80 million cases of dengue fever occur worldwide each year, including a potentially deadly form of the disease called dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). Primary infection with dengue virus results in a self-limiting disease characterized by mild to high fever lasting 3 to 7 days, severe headache with pain behind the eyes, muscle and joint pain, rash, and vomiting. Secondary infection is the more common form of the disease in many parts of Southeast Asia and South America. This form of the disease is more serious and can result in DHF and DSS. The major clinical symptoms can include high fever, hemorrhagic events, and circulatory failure, and the fatality rate can be as high as 40%. Early diagnosis of DSS is particularly important, as patients may die within 12 to 24 h if appropriate treatment is not administered. Primary dengue virus infection is characterized by elevations in specific IgM antibody levels 3 to 5 days after the onset of symptoms; this generally persists for 30 to 60 days. IgG levels also become elevated after 10 to 14 days and remain detectable for life. During secondary infection, IgM levels generally rise more slowly and reach lower levels than in primary infection, while IgG levels rise rapidly from 1 to 2 days after the onset of symptoms. BioVision’s Dengue Virus IgG Capture ELISA kit enables to detect the IgG antibodies to the Dengue virus in human serum and plasma samples. Diluted human serum/plasma samples and anti-human IgG biotinylated antibody are added to the microwell plate pre-coated with Streptavidin. The IgG antibodies in the serum/plasma bind to the anti-human IgG antibody and this complex binds to the Streptavidin-coated plate. Unbound complexes are washed off using wash buffer. The enzyme conjugate is added and any IgG antibodies, if present, will bind to this enzyme conjugate. The color developed as a result of the enzyme-substrate reaction is directly proportional to the amount of IgG antibodies to the Dengue virus in the human serum/plasma samples.

Why buy BioVision Products?
Global Presence
Technical Support
BioVision aims to provide our customers innovative tools for accelerating drug discovery and biological research. BioVision offers >8,000 products including the most comprehensive array of assay kits for key targets in Metabolic pathways.
BioVision is committed to providing the highest quality products at a competitive price.
We have a broad network of global distributors who are ready to address your research needs and ensure fast delivery.
Our highly trained Technical Support team provides comprehensive product support and is dedicated to resolving your issues quickly and efficiently.